Search Count: 15
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-08-11 Classification: HYDROLASE/INHIBITOR Ligands: XPD, ACT, MPD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2021-08-11 Classification: HYDROLASE/INHIBITOR Ligands: XP7, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-08-11 Classification: HYDROLASE/INHIBITOR Ligands: XOV |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2021-08-11 Classification: HYDROLASE/INHIBITOR Ligands: ACT, XOM |
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1S |
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1V |
 |
Identification Of A New Class Of Potent Cdc7 Inhibitors Designed By Putative Pharmacophore Model: Synthesis And Biological Evaluation Of 2,3-Dihydrothieno[3,2-D]Pyrimidin-4(1H)-Ones
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2017-03-29 Classification: TRANSFERASE |
 |
Identification Of A New Class Of Potent Cdc7 Inhibitors Designed By Putative Pharmacophore Model: Synthesis And Biological Evaluation Of 2,3-Dihydrothieno[3,2-D]Pyrimidin-4(1H)-Ones
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.33 Å Release Date: 2017-03-29 Classification: TRANSFERASE Ligands: 81G |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2013-12-11 Classification: APOPTOSIS INHIBITOR Ligands: ZN, 2DX |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2013-12-11 Classification: APOPTOSIS INHIBITOR Ligands: ZN, 2DY |
 |
Crystal Structure Of The Kinase Domain Of Human Vegfr2 With Imidazo[1,2-B]Pyridazine Derivative
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2013-03-06 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 0KF, EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.84 Å Release Date: 2013-01-30 Classification: LIGASE/LIGASE INHIBITOR Ligands: ZN, 1AQ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2013-01-30 Classification: LIGASE/LIGASE INHIBITOR Ligands: ZN, 1BG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2013-01-30 Classification: LIGASE/LIGASE INHIBITOR Ligands: ZN, 1AQ |
 |
Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2011-11-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 42Q |